ATE478666T1 - Antidepressivum - Google Patents
AntidepressivumInfo
- Publication number
- ATE478666T1 ATE478666T1 AT03707169T AT03707169T ATE478666T1 AT E478666 T1 ATE478666 T1 AT E478666T1 AT 03707169 T AT03707169 T AT 03707169T AT 03707169 T AT03707169 T AT 03707169T AT E478666 T1 ATE478666 T1 AT E478666T1
- Authority
- AT
- Austria
- Prior art keywords
- gen
- acyl
- substituted
- benzofused
- protein kinase
- Prior art date
Links
- 230000001430 anti-depressive effect Effects 0.000 title abstract 2
- 239000000935 antidepressant agent Substances 0.000 title abstract 2
- 229940005513 antidepressants Drugs 0.000 title abstract 2
- 108091008611 Protein Kinase B Proteins 0.000 abstract 4
- 102000005765 Proto-Oncogene Proteins c-akt Human genes 0.000 abstract 3
- 125000002252 acyl group Chemical group 0.000 abstract 3
- KAESVJOAVNADME-UHFFFAOYSA-N 1H-pyrrole Natural products C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 abstract 2
- 239000012190 activator Substances 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- -1 azole compound Chemical class 0.000 abstract 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 230000002075 anti-alcohol Effects 0.000 abstract 1
- 230000001773 anti-convulsant effect Effects 0.000 abstract 1
- 230000003178 anti-diabetic effect Effects 0.000 abstract 1
- 230000036436 anti-hiv Effects 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 230000000648 anti-parkinson Effects 0.000 abstract 1
- 239000001961 anticonvulsive agent Substances 0.000 abstract 1
- 239000003472 antidiabetic agent Substances 0.000 abstract 1
- 229960003965 antiepileptics Drugs 0.000 abstract 1
- 239000000939 antiparkinson agent Substances 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 230000001966 cerebroprotective effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000001553 hepatotropic effect Effects 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000001183 hydrocarbyl group Chemical group 0.000 abstract 1
- GWVMLCQWXVFZCN-UHFFFAOYSA-N isoindoline Chemical compound C1=CC=C2CNCC2=C1 GWVMLCQWXVFZCN-UHFFFAOYSA-N 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 210000002569 neuron Anatomy 0.000 abstract 1
- 230000000324 neuroprotective effect Effects 0.000 abstract 1
- 230000001777 nootropic effect Effects 0.000 abstract 1
- 125000001997 phenyl group Chemical class [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229940125725 tranquilizer Drugs 0.000 abstract 1
- 239000003204 tranquilizing agent Substances 0.000 abstract 1
- 230000002936 tranquilizing effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/4035—Isoindoles, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/443—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compounds Of Unknown Constitution (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002055771 | 2002-03-01 | ||
| JP2002195434 | 2002-07-04 | ||
| PCT/JP2003/002293 WO2003074046A1 (en) | 2002-03-01 | 2003-02-28 | Antidepressant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE478666T1 true ATE478666T1 (de) | 2010-09-15 |
Family
ID=27790932
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03707169T ATE478666T1 (de) | 2002-03-01 | 2003-02-28 | Antidepressivum |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20050148650A1 (de) |
| EP (1) | EP1481679B1 (de) |
| JP (1) | JP2010111698A (de) |
| KR (1) | KR101011657B1 (de) |
| CN (1) | CN1638763A (de) |
| AT (1) | ATE478666T1 (de) |
| AU (1) | AU2003211261A1 (de) |
| CA (1) | CA2477903C (de) |
| DE (1) | DE60333902D1 (de) |
| NO (1) | NO20043786L (de) |
| PL (1) | PL371366A1 (de) |
| WO (1) | WO2003074046A1 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7652191B2 (en) * | 2003-03-19 | 2010-01-26 | Bar Ilan University | Nonhuman mammals exhibiting PTSD-like behavior |
| JP2010509188A (ja) * | 2006-11-09 | 2010-03-25 | 武田薬品工業株式会社 | 医薬組成物 |
| EP2250176B1 (de) * | 2008-01-30 | 2012-08-01 | Cephalon, Inc. | Substituierte spirocyclische piperidinderivate als histamin-3-(h3)rezeptorliganden |
| WO2010104194A1 (en) | 2009-03-10 | 2010-09-16 | Takeda Pharmaceutical Company Limited | Benzofuran derivatives |
| US8828924B2 (en) * | 2009-05-14 | 2014-09-09 | University Of Maryland, Baltimore | Methods of treating a diabetic embryopathy |
| WO2013035826A1 (ja) * | 2011-09-08 | 2013-03-14 | 武田薬品工業株式会社 | 縮合複素環化合物 |
| US11071793B2 (en) * | 2014-08-29 | 2021-07-27 | Chdi Foundation, Inc. | Probes for imaging huntingtin protein |
| WO2018172527A1 (en) * | 2017-03-24 | 2018-09-27 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical composition for the treatment of neurodegenerative disease |
| WO2020163689A1 (en) | 2019-02-08 | 2020-08-13 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | 20-hete formation inhibitors |
| MX2024000313A (es) | 2021-07-09 | 2024-03-06 | Plexium Inc | Compuestos de arilo y composiciones farmaceuticas que modulan la ikzf2. |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4799934A (en) | 1987-10-30 | 1989-01-24 | Clairol Incorporated | Sulfur-containing nitroaminobenzene dyes, process and hair dye compositions |
| EP0539709A1 (de) * | 1991-09-18 | 1993-05-05 | FUJIREBIO Inc. | 3,5-Dihydroxyheptansäurederivate und deren Lactone als HMG-CoA-Reduktase-Inhibitoren |
| US5854204A (en) | 1995-03-14 | 1998-12-29 | Praecis Pharmaceuticals, Inc. | Aβ peptides that modulate β-amyloid aggregation |
| CA2262453A1 (en) | 1996-08-27 | 1998-03-05 | Praecis Pharmaceuticals Incorporated | Modulators of .beta.-amyloid peptide aggregation comprising d-amino acids |
| EP0988289A2 (de) * | 1997-06-05 | 2000-03-29 | Takeda Pharmaceutical Company Limited | Benzofurane und benzothiophene als unterdrücker der neurodegeneration |
| JPH1149765A (ja) * | 1997-06-05 | 1999-02-23 | Takeda Chem Ind Ltd | 複素環化合物、その製造法および剤 |
| JP2002527419A (ja) | 1998-10-08 | 2002-08-27 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | Ｇｓｋ−３阻害物質としてのピロール−２，５−ジオン類 |
| WO2000034262A1 (en) * | 1998-12-04 | 2000-06-15 | Takeda Chemical Industries, Ltd. | Benzofuran derivatives, process for the preparation of the same and uses thereof |
| CA2374346C (en) | 1999-06-28 | 2010-06-22 | Jordan J. N. Tang | Inhibitors of memapsin 2 and use thereof |
| JP2002201172A (ja) * | 2000-02-25 | 2002-07-16 | Japan Tobacco Inc | ベンズアミド誘導体及びその用途 |
| WO2001068666A1 (en) * | 2000-03-14 | 2001-09-20 | Thomas Jefferson University | Tcl1 enhances akt kinase activity and mediates its nuclear translocation |
| GB0022333D0 (en) | 2000-09-12 | 2000-10-25 | Glaxo Group Ltd | Methods for identifying modulators of protein interactions |
| JP2002348239A (ja) | 2000-10-05 | 2002-12-04 | Takeda Chem Ind Ltd | 幹細胞・神経前駆細胞の増殖・分化促進剤 |
| WO2002028850A1 (en) * | 2000-10-05 | 2002-04-11 | Takeda Chemical Industries, Ltd. | Promoters for the proliferation and differentiation of stem cells and/or neuron precursor cells |
| ATE414070T1 (de) * | 2000-12-28 | 2008-11-15 | Takeda Pharmaceutical | Verfahren zur herstellung von optisch aktiven 2,4-dihydrobenzofuranverbindungen |
| US7153871B2 (en) * | 2001-01-22 | 2006-12-26 | Memory Pharmaceuticals Corporation | Phosphodiesterase 4 inhibitors, including aminoindazole and aminobenzofuran analogs |
| US6566550B2 (en) * | 2001-06-21 | 2003-05-20 | Pfizer Inc | Substituted aromatic ethers as inhibitors of glycine transport |
| WO2003004485A1 (fr) * | 2001-07-05 | 2003-01-16 | Takeda Chemical Industries, Ltd. | Composes heterocycles a 5 chainons condenses avec un benzo, leur procede de preparation et leur utilisation |
-
2003
- 2003-02-28 PL PL03371366A patent/PL371366A1/xx not_active Application Discontinuation
- 2003-02-28 CA CA2477903A patent/CA2477903C/en not_active Expired - Fee Related
- 2003-02-28 AT AT03707169T patent/ATE478666T1/de not_active IP Right Cessation
- 2003-02-28 DE DE60333902T patent/DE60333902D1/de not_active Expired - Lifetime
- 2003-02-28 CN CNA038048728A patent/CN1638763A/zh active Pending
- 2003-02-28 WO PCT/JP2003/002293 patent/WO2003074046A1/ja not_active Ceased
- 2003-02-28 US US10/506,269 patent/US20050148650A1/en not_active Abandoned
- 2003-02-28 KR KR1020047013566A patent/KR101011657B1/ko not_active Expired - Fee Related
- 2003-02-28 EP EP03707169A patent/EP1481679B1/de not_active Expired - Lifetime
- 2003-02-28 AU AU2003211261A patent/AU2003211261A1/en not_active Abandoned
-
2004
- 2004-09-09 NO NO20043786A patent/NO20043786L/no not_active Application Discontinuation
-
2006
- 2006-06-27 US US11/475,539 patent/US7750037B2/en not_active Expired - Fee Related
-
2010
- 2010-01-13 JP JP2010005081A patent/JP2010111698A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| US20060241168A1 (en) | 2006-10-26 |
| EP1481679A1 (de) | 2004-12-01 |
| DE60333902D1 (de) | 2010-10-07 |
| CN1638763A (zh) | 2005-07-13 |
| PL371366A1 (en) | 2005-06-13 |
| WO2003074046A1 (en) | 2003-09-12 |
| EP1481679B1 (de) | 2010-08-25 |
| EP1481679A4 (de) | 2005-11-23 |
| HK1070273A1 (en) | 2005-06-17 |
| KR20040096636A (ko) | 2004-11-16 |
| CA2477903C (en) | 2010-10-12 |
| JP2010111698A (ja) | 2010-05-20 |
| NO20043786L (no) | 2004-09-09 |
| US7750037B2 (en) | 2010-07-06 |
| US20050148650A1 (en) | 2005-07-07 |
| KR101011657B1 (ko) | 2011-01-28 |
| AU2003211261A1 (en) | 2003-09-16 |
| CA2477903A1 (en) | 2003-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60333902D1 (de) | Antidepressivum | |
| EP1036794A4 (de) | 2-aryl-8-oxodihydropurin-derivate, ihre herstellung, ihre verwendung als medikamentenkomponente und deren intermediate | |
| EP1489078A4 (de) | Benzofuranderivat | |
| MY125506A (en) | Benzodiazepine derivatives as metabotropic glutamate receptor antagonists | |
| DK1680418T3 (da) | Derivater af N-(heteroaryl-(piperidin-2yl)methyl)benzamid, deres fremstilling og deres anvendelse som terapeutika | |
| DE69528257D1 (de) | KONDENSIERTE HETEROCYCLISCHE VERBINDUNG, DEREN HERSTELLUNG UND VERWENDUNG ALS GnRH ANTAGONISTEN | |
| EP1312601A4 (de) | Carbonsäurederivate, verfahren zu deren herstellung und medikamente, die diese als wirkstoff enthalten | |
| EA200500037A1 (ru) | Фенилбензамиды | |
| ATE527247T1 (de) | Benzokondensierte 5gliedrige heterocyclische verbindungen, verfahren zu deren herstellung und deren verwendung | |
| ATE347356T1 (de) | Hydroxamsäurederivate als antibakterielle arzneimittel | |
| TR199900477T2 (xx) | Thiazolil-alanin art��� ihtiva eden yeni peptid t�revleri. | |
| CA2226886A1 (en) | N-(4-substituted-benzyl)-2-aminolactam derivatives | |
| CY1110613T1 (el) | Υποκατεστημενες θειαζολες και η χρησιμοποιηση τους για την παρασκευη φαρμακων | |
| DE69625709D1 (de) | Alpha-substituierte heterozyklische benzylderivate, zwischenverbindungen zu ihrer herstellung und pestizide die diese als aktiver bestandteil enthalten | |
| PT1165485E (pt) | Processo para a preparacao de produtos intermediarios pesticidas | |
| ATE272048T1 (de) | Aminosäuren mit polycyclischer struktur als pharmaka | |
| BR9611572A (pt) | Produção de um sal de ácido clavulânico | |
| BR9307232A (pt) | 4-Estrenos ligados por meio de ponte-19,11 com efic cia gestag-nica | |
| ATE176235T1 (de) | Verwendung von cephem-derivaten als antimetastatische mittel | |
| EP1000933A4 (de) | Trifluoro-methylthiomethyl-benzolderivate und verfahren zu ihrer herstellung | |
| DK0862551T3 (da) | Floursubstituerede benzoylpropionsyrederivater | |
| AU6595000A (en) | Dihydrobenzofuran derivatives, process for the preparation thereof and agents | |
| AU2001295949A1 (en) | Process for preparation of optically active sulfonamides and intermediates for their synthesis | |
| ATE298744T1 (de) | Amycomycin, verfahren zu dessen herstellung und seine verwendung als arzneimittel | |
| ES2150073T3 (es) | Nuevos agentes fungicidas ll-15g256gamma, delta y epsilon, producidos por el ll-15g256 (hypoxylon oceanicum). |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |